You must log in to view this page.

Atea Pharmaceuticals Inc. – Ownership Summary

NASDAQ: AVIR
Share price (4/8/26): $5.93
Market cap (4/8/26): $472 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Google Finance
SEC EDGAR

Insider Ownership

Corcoran Andrea »

12/34/56

144

12/34/56

Sommadossi Jean-Pierre »

12/34/56

SCHEDULE 13G/A

12/34/56

≥5% Ownership

Vanguard Group Inc »

SCHEDULE 13G/A

SC 13G/A

SC 13G/A

SC 13G

BML Investment Partners, L.P. »

SCHEDULE 13G

SCHEDULE 13D

SC 13G

SC 13G/A

SC 13G

Atea Pharmaceuticals Inc. – Ownership Summary Watch

Search in Documents

Key Exhibits

External Links

Insider Ownership

Corcoran Andrea »

Sommadossi Jean-Pierre »

≥5% Ownership

Vanguard Group Inc »

BML Investment Partners, L.P. »

Atea Pharmaceuticals Inc. – Ownership Summary